AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Depreciation & Amortization (CF) (2020 - 2026)

AtaiBeckley (ATAI) posted Depreciation & Amortization (CF) of $233000.0 for Q3 2025, up 2.64% sequentially from $227000.0 in Q2 2025, and up 180.72% YoY from $83000.0 in Q3 2024.

Analysis

AtaiBeckley (ATAI) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

AtaiBeckley's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $167000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 22.69% year-over-year to $167000.0; the TTM figure through Mar 2026 stood at $383000.0 (changed N/A YoY), while the FY2025 annual figure was $1.0 million, up 113.95% from the prior year.
  • Depreciation & Amortization (CF) climbed to $233000.0 in Q3 2025 per ATAI's latest filing, from $227000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $216000.0 in Q1 2025, with the low at $167000.0 in Q1 2026.
  • A 5-year average of $88578.9 and a median of $74000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) plunged 240.0% in 2021, then jumped 900.0% in 2022.
  • Over 5 years, Depreciation & Amortization (CF) stood at $29000.0 in 2021, then surged by 82.76% to $53000.0 in 2022, then surged by 90.57% to $101000.0 in 2023, then jumped by 122.77% to $225000.0 in 2024, then grew by 3.56% to $233000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $233000.0, $227000.0, and $216000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AtaiBeckley 1.61 Bn 1.61 Bn - 233,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 215,000.00
Mar 31, 2026 167,000.00
Sep 30, 2025 233,000.00
Jun 30, 2025 227,000.00
Jun 30, 2025 227,000.00
Mar 31, 2025 216,000.00
Mar 31, 2025 216,000.00
Dec 31, 2024 225,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 82,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 74,000.00
Jun 30, 2023 79,000.00
Mar 31, 2023 65,000.00
Dec 31, 2022 53,000.00
Sep 30, 2022 36,000.00
Jun 30, 2022 19,000.00
Mar 31, 2022 60,000.00
Dec 31, 2021 29,000.00